A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia
Public ClinicalTrials.gov record NCT07038876. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Orally Administered ML-007C-MA in Inpatient Adult Participants With Schizophrenia Experiencing an Acute Exacerbation of Psychosis
Study identification
- NCT ID
- NCT07038876
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- MapLight Therapeutics
- Industry
- Enrollment
- 307 participants
Conditions and interventions
Conditions
Interventions
- ML-007C-MA BID Drug
- ML-007C-MA QD Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 26, 2025
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
- Last update posted
- May 17, 2026
2025 – 2026
United States locations
- U.S. sites
- 24
- U.S. states
- 9
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site | Little Rock | Arkansas | 72211 | — |
| Clinical Site | Bellflower | California | 90706 | — |
| Clinical Site | Culver City | California | 90230 | — |
| Clinical Site | Garden Grove | California | 92845 | — |
| Clinical Site | Lemon Grove | California | 91945 | — |
| Clinical Site | Los Angeles | California | 90015 | — |
| Clinical Site | Montclair | California | 91763 | — |
| Clinical Site | Orange | California | 92868 | — |
| Clinical Site | Riverside | California | 92506 | — |
| Clinical Site | San Diego | California | 92123 | — |
| Clinical Site | Sherman Oaks | California | 91403 | — |
| Clinical Site | Torrance | California | 90504 | — |
| Clinical Site | Hollywood | Florida | 33024 | — |
| Clinical Site | Miami Lakes | Florida | 33016 | — |
| Clinical Site | West Palm Beach | Florida | 33407 | — |
| Clinical Site | Atlanta | Georgia | 30331 | — |
| Clinical Site | Decatur | Georgia | 30030 | — |
| Clinical Site | Chicago | Illinois | 60640 | — |
| Clinical Site | Marlton | New Jersey | 08053 | — |
| Clinical Site | Staten Island | New York | 10314 | — |
| Clinical Site | North Canton | Ohio | 44720 | — |
| Clinical Site | Austin | Texas | 78754 | — |
| Clinical Site | DeSoto | Texas | 75115 | — |
| Clinical Site | Richardson | Texas | 75080 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07038876, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 17, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07038876 live on ClinicalTrials.gov.